Skip to main content

Life Sciences & Healthcare

Rapid transformation in the life sciences and healthcare industry can require businesses to strike a balance between patient demands, market potential and policy compliance, while continuing to innovate. We create solutions that can help you to remain competitive in this constantly evolving market. 

For a more innovative, equitable and sustainable future

Innovation is blurring the traditional boundaries in the life sciences and health care industry. Our extensive industry experience, differentiated market research, data and insights give us a comprehensive understanding of the opportunities and challenges of the changing health care ecosystem. 

We are positioned to help you drive your business forwards—not only because we understand complex problems, but because we have the skills, tools and multi-disciplinary solutions to help solve them. Through deep understanding of our vision of the Future of Health™, health equity and digital transformation, we can help you navigate the industry’s transformation as exponential innovation propels health care to the future.

Our Thinking

Empowering the Health Care workforce for a climate-resilient future

In this report, Project HOPE and Deloitte US have brought together frontline Healthcare workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders and strategic relationships to collaborate on potential solutions for enhancing climate resilience.

Find out more

Platform business models: Private Equity opportunities in the Life Sciences and Healthcare sector

Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.

Find out more

Electronic Health Records Solution

Deloitte's Electronic Health Record (EHR) solution helps health systems execute Digital Transformation that shifts legacy models into modern best practices anchored on elevating the human experience.

Find out more

2024 Global Life Sciences Sector Outlook

With the global pandemic firmly in the rearview mirror, Life Sciences companies are looking at key macro- and micro-economic drivers to guide their future growth.

Find out more

A path toward health equity

The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.

Find out more

Deloitte at HLTH Europe

From digital health to biotech and from digital therapeutics to Healthcare IT innovations, there’s a community and a conversation about it at HLTH Europe event.

Find out more

2024 Global Healthcare Sector Outlook

The global Healthcare sector is undergoing a period of unprecedented transformation, driven by technological advancements, demographic shifts and evolving patient needs. In 2024, several key trends are poised to shape the Future of Healthcare delivery. How can sector leaders and stakeholders prepare themselves for this profound change?

Find out more

The Deloitte Health Equity Institutes

Learn more about the specific actions the Deloitte Health Equity Institutes are taking to foster health equity for all.

Find out more

Securing trust in the global supply chain of COVID-19 vaccines

The critical success factors identified in 2020 remain paramount. But now stakeholders need to act on the lessons learnt to strengthen the collective ability to respond to or—better yet—proactively address the existing global health issues.

Find out more

The promise of digital mental health in a meta world

A Deloitte and World Economic Forum report

Find out more

Deloitte recognised as a Leader in Everest Group Life Sciences Smart Manufacturing Services PEAK Matrix® Assessment 2023

Read more